| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9429567 | Neuroscience Letters | 2005 | 4 Pages |
Abstract
Our results show that genotyping â141C Ins/Del may help to predict the efficacy of chlorpromazine treatment (PÂ =Â 0.01) due to the fact that patients with no Del allele showed greater improvement than those with Del allele on the overall BPRS (PÂ =Â 0.03), and that, therefore, the potential for therapy in patients with schizophrenia is related to the â141C Ins/Del polymorphism in the DRD2 gene. However, no such relationship was found for the TaqI A polymorphism.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Shengnan Wu, Qinghe Xing, Rui Gao, Xingwang Li, Niufan Gu, Guoyin Feng, Lin He,